Pharmaceutical Technology, Apr 2, 2010 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharmaceutical Technology, Apr 2, 2010
Online Exclusives
ISPE Raises the Bar for Baseline Guides
By Susan J. Schniepp
New information improves an organization's guide to building manufacturing facilities.
Special Report
Spending More or Less, and on What?
By Patricia Van Arnum
Pharmaceutical Technology's annual survey on equipment and machinery reveals the spending levels and types of spending made in 2009 and planned for 2010.
Tracking Solid-Dosage Equipment
By Patricia Van Arnum
Tablets and capsules are mainstay product forms, so what are the spending and innovation trends for solid-dosage manufacturing equipment and machinery?
The Evolution of Single-Use Technologies in Aseptic Processing
By Maik W. Jornitz , Thomas Paust
The authors describe the origins of single-use components and explain their application to aseptic processes. They also show how disposable devices have changed over time and offer a glimpse of the future.
Ingredients Insider
Moving to the Next Level in Biomanufacturing
By Patricia Van Arnum
Growth in the market for monoclonal antibodies, recombinant proteins, and vaccines creates new opportunities for drug companies and suppliers.
Peer-Reviewed Research
Reduced-Method Robustness Testing of Analytical Methods Driven by a Risk-Based Approach
By Phil Borman , Marion Chatfield , Patrick Jackson , Alice Laures , George Okafo
The authors describe a novel approach for assessing method robustness. This article contains online-bonus material and was copublished with Pharmaceutical Technology Europe.
Spherical Crystallization for Lean Solid-Dosage Manufacturing (Part II)
By Tu Lee , Yan Chan Su , Hung Ju Hou , Hsiang Yu Hsieh
In Part I of this article, which appeard in the March 2010 issue, the authors describe their approach for constructing form spaces for carbamazepine, cimetidine, and phenylbutazone by initial solvent screening to evaluate the feasibility of spherical crystallization. Part II of this article discusses their findings.
The Effect of Overencapsulation on Disintegration and Dissolution
By Fredrick Esseku , Mark Lesher , Vishal Bijlani , Samantha Lai , Ewart Cole , Moji Christianah Adeyeye
The authors examined the disintegration and dissolution profiles of propranolol and rofecoxib tablets overencapsulated with standard hard-gelatin capsules and with capsules specifically designed for double-blind clinical trials.
Guest Editorial
More Questions than Answers
By Bob Stewart
As the industry continues to evolve, do we know where we're headed?
PharmTech Talk
Stay Current at INTERPHEX
By Erik Greb
An established show has several new programs that reflect the industry's current challenges.
Agent-in Place
Unconventional Communication
By Control, a senior compliance officer
Laboratory personnel share interesting tales as well as stories of unexpected tails.
In the Spotlight
In the Spotlight
Editors' Picks of Pharmaceutical Science and Technology Innovations
News
Report from Asia
By Jane Wan
As demand for global vaccine development and production grows, all eyes are turning to Asia.
Washington Report
Risks and Realities of REMS
By Jill Wechsler
FDA lacks resources to manage expanding postmarketing responsibilities.
Packaging Forum
BFS Equipment Streamlines the Packaging Process
By Hallie Forcinio
Aseptic blow–fill–seal minimizes human intervention in the packaging process.
Inside USP
Inside USP: USP Reaches 2500 Reference Standards
By William F. Koch
Collaboration has been key to the pharmacopeia's achievement.
Inside EDQM
Inside EDQM: The Role of the Pharmacopeia in a Globalized World
By Susanne Keitel
As drug manufacturing and standards grow, pharmacopeias must adapt to meet new challenges.
Outsourcing Outlook
Waste Not, Want Not
By Eric Langer
Restructuring in the biopharmaceutical industry is renewing a focus on resource optimization.
Industry Leaders: Q&A
Glatt Air's Executive Vice-President on Innovation
Steve Sirabian discusses challenges, trends, and more.
Industry Pipeline
Industry Pipeline
Interphex Showcase 2010.
Viewpoint
Delivering on the Promise of Biotechnology
By James C. Greenwood
The BIO convention, and healthcare reform, could re-energize biotech.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here